Enhancing schizophrenia treatment efficacy: The combined impact of Yueju pill and olanzapine through quercetin target modulation

doi:10.5498/wjp.v15.i10.101658

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 10

This Article

(42)

(52)

(0)

(14)

(983)

(3)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Psychiatry. Oct 19, 2025; 15(10): 101658
Published online Oct 19, 2025. doi: 10.5498/wjp.v15.i10.101658

Full Size Figure Download Figure

Figure 6 Analysis of changes in serum brain-derived neurotrophic factor, dopamine, and serotonin levels before and after treatment in schizophrenia patients. A: Analysis of changes in serum brain-derived neurotrophic factor levels before and after treatment in schizophrenia patients; B: Analysis of changes in serum serotonin levels before and after treatment in schizophrenia patients; C: Analysis of changes in serum dopamine levels before and after treatment in schizophrenia patients (intervention group = 48 cases, control group = 49 cases). ¹Indicates a significant difference before and after the intervention; ^aP < 0.05. NS: Not significance; BDNF: Brain-derived neurotrophic factor; 5-HT: Serotonin; DA: Dopamine.

Citation: Zhu DM, Lu Y, Xiao XD, Sun Y, Tao G, Long B, Zhao J. Enhancing schizophrenia treatment efficacy: The combined impact of Yueju pill and olanzapine through quercetin target modulation. World J Psychiatry 2025; 15(10): 101658
URL: https://www.wjgnet.com/2220-3206/full/v15/i10/101658.htm
DOI: https://dx.doi.org/10.5498/wjp.v15.i10.101658

Zhu DM, Lu Y, Xiao XD, Sun Y, Tao G, Long B, Zhao J. Enhancing schizophrenia treatment efficacy: The combined impact of Yueju pill and olanzapine through quercetin target modulation. World J Psychiatry 2025; 15(10): 101658 [PMID: 41112622 DOI: 10.5498/wjp.v15.i10.101658]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.